Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Inefficient vascular supply and the resultant reduction in tissue oxygen tension often lead to neovascularization in order to satisfy the needs of the tissue. Examples include the compensatory development of collateral blood vessels in ischaemic tissues that are otherwise quiescent for angiogenesis and angiogenesis associated with the healing of hypoxic wounds. But the presumptive hypoxia-induced angiogenic factors that mediate this feedback response have not been identified. Here we show that vascular endothelial growth factor (VEGF; also known as vascular permeability factor) probably functions as a hypoxia-inducible angiogenic factor. VEGF messenger RNA levels are dramatically increased within a few hours of exposing different cell cultures to hypoxia and return to background when normal oxygen supply is resumed. In situ analysis of tumour specimens undergoing neovascularization show that the production of VEGF is specifically induced in a subset of glioblastoma cells distinguished by their immediate proximity to necrotic foci (presumably hypoxic regions) and the clustering of capillaries alongside VEGF-producing cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cells grown under hypoxic conditions activate transcription of vascular endothelial growth factor (VEGF) (Shweiki et al., 1992;Forsythe et al., 1996), which is important for endothelial cell activation and proliferation.”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Shweiki et al., 1992
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,061
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476
Differentiated Rat Glial Cell Strain in Tissue Culture
Benda, P., Lightbody, J., Sato, G., Levine, L., & Sweet, W. (1968) · Science · doi:10.1126/science.161.3839.370 · Cited by 1,472
Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.
Connolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., & Feder, J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114322 · Cited by 1,265
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60946-x · Cited by 1,071
Vlodavsky, I., Folkman, J., Sullivan, R., Fridman, R., Ishai-Michaeli, R., Sasse, J., & Klagsbrun, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.8.2292 · Cited by 1,032
Research works printed but not linked: 2
- Adair, T. A., Gay, W. J. & Montani, J.-P. Am. J. Physiol. 259, R393–R404 (1990).
- Knighton, D., Schumerth, S. & Fiegel, V. in Current Communications in Molecular Biology (eds Rifkin, D. B. & Klagsbrun, M.) 150–154 (Cold Spring Harbor Laboratory Press, New York, 1987).
Cited by
Items 701–800 of 1,033
Mesenchymal stem cells and neovascularization: role of platelet‐derived growth factor receptors
Ball, S. G., Shuttleworth, C. A., & Kielty, C. M. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00120.x · Cited by 178
New Insights Into Molecular Mechanisms of Diabetic Kidney Disease
Badal, S. S., & Danesh, F. R. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.10.047 · Cited by 182
Thrombospondins and tumor angiogenesis
de Fraipont, F., Nicholson, A. C., Feige, J.-J., & Van Meir, E. G. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02102-5 · Cited by 178
Christou, H., Yoshida, A., Arthur, V., Morita, T., & Kourembanas, S. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.18.6.2980 · Cited by 183
Berisha, B., Schams, D., Kosmann, M., Amselgruber, W., & Einspanier, R. (2000) · Biology of Reproduction · doi:10.1095/biolreprod63.4.1106 · Cited by 182
Akagi, Y., Liu, W., Zebrowski, B. K., Xie, K., & Ellis, L. M. (1998) · PubMed · Cited by 184
Mitsuhashi, N., Shimizu, H., Ohtsuka, M., Wakabayashi, Y., Ito, H., Kimura, F., Yoshidome, H., Kato, A., Nukui, Y., & Miyazaki, M. (2003) · Hepatology · doi:10.1053/jhep.2003.50204 · Cited by 183
Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells
Chua, C. C., Hamdy, R. C., & Chua, B. H. L. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(97)00129-8 · Cited by 178
Hypoxia signalling in the control of erythropoietin gene expression in rat hepatocytes
Göpfert, T., Gess, B., Eckardt, K., & Kurtz, A. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199608)168:2<284::aid-jcp7>3.0.co;2-l · Cited by 27
Marschall, Z. V., Cramer, T., Höcker, M., Finkenzeller, G., Wiedenmann, B., & Rosewicz, S. (2001) · Gut · doi:10.1136/gut.48.1.87 · Cited by 183
Bao, B., Azmi, A. S., Ali, S., Ahmad, A., Li, Y., Banerjee, S., Kong, D., & Sarkar, F. H. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.008 · Cited by 180
Proescholdt, M. A., Jacobson, S., Tresser, N., Oldfield, E. H., & Merrill, M. J. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.10.914 · Cited by 182
Identification of a Human VPF/VEGF 3′ Untranslated Region Mediating Hypoxia-induced mRNA Stability
Claffey, K. P., Shih, S.-C., Mullen, A., Dziennis, S., Cusick, J. L., Abrams, K. R., Lee, S. W., & Detmar, M. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.2.469 · Cited by 177
Podokinesis in endothelial cell migration: role of nitric oxide
Noiri, E., Lee, E., Testa, J., Quigley, J., Colflesh, D., Keese, C. R., Giaever, I., & Goligorsky, M. S. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.1.c236 · Cited by 184
Expression and distribution of vascular endothelial growth factor protein in human brain tumors
Pietsch, T., Valter, M. M., Wolf, H. K., von Deimling, A., Huang, H.-J. S., Cavenee, W. K., & Wiestler, O. D. (1997) · Acta Neuropathologica · doi:10.1007/s004010050591 · Cited by 180
‘Accidental’ anti-angiogenic drugs
Kerbel, R. S., Viloria-Petit, A., Klement, G., & Rak, J. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00092-7 · Cited by 182
Sato, K., Yamazaki, K., Shizume, K., Kanaji, Y., Obara, T., Ohsumi, K., Demura, H., Yamaguchi, S., & Shibuya, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118164 · Cited by 179
Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective
Chan-Ling, T., Gole, G. A., Quinn, G. E., Adamson, S. J., & Darlow, B. A. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.09.002 · Cited by 176
Vascularization Strategies in Bone Tissue Engineering
Simunovic, F., & Finkenzeller, G. (2021) · Cells · doi:10.3390/cells10071749 · Cited by 168
Green, C. J., Lichtlen, P., Huynh, N., Yanovsky, M., Laderoute, K. R., Schaffner, W., & Murphy, B. J. (2001) · PubMed · Cited by 198
Chen, H., Treweeke, A. T., West, D. C., Till, K. J., Cawley, J. C., Zuzel, M., & Toh, C. H. (2000) · Blood · doi:10.1182/blood.v96.9.3181 · Cited by 180
Ankoma-Sey, V., Wang, Y., & Dai, Z. (2000) · Hepatology · doi:10.1002/hep.510310122 · Cited by 179
Obrosova, I. G., Minchenko, A. G., Marinescu, V., Fathallah, L., Kennedy, A., Stockert, C. M., Frank, R. N., & Stevens, M. J. (2001) · Diabetologia · doi:10.1007/s001250100631 · Cited by 179
Jackson, M. R., Carney, E. W., Lye, S. J., & Knox Ritchie, J. W. (1994) · Placenta · doi:10.1016/0143-4004(94)90002-7 · Cited by 176
Kong, H.-L., Hecht, D., Song, W., Kovesdi, I., Hackett, N. R., Yayon, A., & Crystal, R. G. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.6-823 · Cited by 180
Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity
Martin, J. D., Fukumura, D., Duda, D. G., Boucher, Y., & Jain, R. K. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027094 · Cited by 175
Sun, Y., Jin, K., Childs, J. T., Xie, L., Mao, X. O., & Greenberg, D. A. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2005.10.016 · Cited by 178
“…vascular endothelial growth factor (VEGF) family of proteins were identified based on their angiogenic and vessel permeability-inducing properties (Keck et al., 1989; Leung et al., 1989) and were subsequently found to couple hypoxia to angiogenesis in a wide range of tissues (Shweiki et al., 1992).”
BackgroundVascular Dysfunction in Preeclampsia
Brennan, L. J., Morton, J. S., & Davidge, S. T. (2014) · Microcirculation · doi:10.1111/micc.12079 · Cited by 158
Hypoxia as a target for combined modality treatments
Wouters, B. G., Weppler, S. A., Koritzinsky, M., Landuyt, W., Nuyts, S., Theys, J., Chiu, R. K., & Lambin, P. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00361-6 · Cited by 180
Mu, D., Jiang, X., Sheldon, R. A., Fox, C. K., Hamrick, S. E. G., Vexler, Z. S., & Ferriero, D. M. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.020 · Cited by 179
Antiangiogenic and Antitumor Activities of IL-27
Shimizu, M., Shimamura, M., Owaki, T., Asakawa, M., Fujita, K., Kudo, M., Iwakura, Y., Takeda, Y., Luster, A. D., Mizuguchi, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7317 · Cited by 177
INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR CENTRAL AND HEMICENTRAL RETINAL VEIN OCCLUSIONS: IBeVO Study
COSTA, R. A., JORGE, R., CALUCCI, D., MELO, L. A., CARDILLO, J. A., & SCOTT, I. U. (2007) · Retina · doi:10.1097/iae.0b013e31802eff83 · Cited by 180
Liver metastasis formation by laminin-1 peptide (LQVQLSIR)-adhesion selected B16-F10 melanoma cells
Song, S.-Y., Nomizu, M., Yamada, Y., & Kleinman, H. K. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970502)71:3<364::aid-ijc10>3.0.co;2-g · Cited by 57
Jeziorska, M., & Woolley, D. E. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199906)188:2<189::aid-path336>3.0.co;2-n · Cited by 176
Stretch-induced VEGF expression in the heart.
Li, J., Hampton, T., Morgan, J. P., & Simons, M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119510 · Cited by 175
Serum vascular endothelial growth factor is often elevated in disseminated cancer.
Salvén, P., Mänpää, H., Orpana, A., Alitalo, K. K., & Joensuu, H. (1997) · PubMed · Cited by 188
Tissue Inhibition of Angiotensin-Converting Enzyme Activity Stimulates Angiogenesis In Vivo
Fabre, J.-E., Rivard, A., Magner, M., Silver, M., & Isner, J. M. (1999) · Circulation · doi:10.1161/01.cir.99.23.3043 · Cited by 178
Chan, A. S. Y., Leung, S. Y., Wong, M. P., Yuen, S. T., Cheung, N., Fan, Y. W., & Chung, L. P. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199807000-00004 · Cited by 177
Rupec, R. A., & Baeuerle, P. A. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.632_b.x · Cited by 180
Yan, S.-F., Zou, Y. S., Gao, Y., Zhai, C., Mackman, N., Lee, S. L., Milbrandt, J., Pinsky, D., Kisiel, W., & Stern, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8298 · Cited by 177
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis
Jubb, A. M., Buffa, F. M., & Harris, A. L. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00944.x · Cited by 175
Cyclooxygenase‐2 modulates cellular growth and promotes tumorigenesis
Trifan, O. C., & Hla, T. (2003) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2003.tb00222.x · Cited by 176
Vascular Endothelial Growth Factor-B in Physiology and Disease
Bry, M., Kivelä, R., Leppänen, V.-M., & Alitalo, K. (2014) · Physiological Reviews · doi:10.1152/physrev.00028.2013 · Cited by 173
Mediators of ocular angiogenesis
Qazi, Y., Maddula, S., & Ambati, B. K. (2009) · Journal of Genetics · doi:10.1007/s12041-009-0068-0 · Cited by 170
CD105 prevents apoptosis in hypoxic endothelial cells
Li, C., Issa, R., Kumar, P., Hampson, I. N., Lopez-Novoa, J. M., Bernabeu, C., & Kumar, S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00470 · Cited by 174
Lukyanov, A. N., Hartner, W. C., & Torchilin, V. P. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.10.008 · Cited by 171
Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy.
Pe'er, J., Folberg, R., Itin, A., Gnessin, H., Hemo, I., & Keshet, E. (1996) · British Journal of Ophthalmology · doi:10.1136/bjo.80.3.241 · Cited by 174
Self-citationSchaefer, L. K., Ren, Z., Fuller, G. N., & Schaefer, T. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205263 · Cited by 170
Griffiths, L. A., Dachs, G. U., Bicknell, R., Harris, A. L., & Stratford, I. J. (1997) · PubMed · Cited by 175
Labler, L., Rancan, M., Mica, L., Härter, L., Mihic-Probst, D., & Keel, M. (2009) · Journal of Trauma: Injury, Infection & Critical Care · doi:10.1097/ta.0b013e318171971a · Cited by 172
Nonoguchi, N., Miyatake, S.-I., Fukumoto, M., Furuse, M., Hiramatsu, R., Kawabata, S., Kuroiwa, T., Tsuji, M., Fukumoto, M., & Ono, K. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0610-9 · Cited by 172
Hershey, J. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00232-7 · Cited by 174
Stimulation of angiogenesis by Ras proteins
Kranenburg, O., Gebbink, M. F. B. G., & Voest, E. E. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2003.09.004 · Cited by 168
Modulation of Growth Factor Action: Implications for the Treatment of Cardiovascular Diseases
Waltenberger, J. (1997) · Circulation · doi:10.1161/01.cir.96.11.4083 · Cited by 177
Heterogeneity of Tumor Endothelial Cells
Ohga, N., Ishikawa, S., Maishi, N., Akiyama, K., Hida, Y., Kawamoto, T., Sadamoto, Y., Osawa, T., Yamamoto, K., Kondoh, M., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.11.035 · Cited by 166
Expression of vascular endothelial growth factor protein in human renal cell carcinoma
Jacobsen, J., Grankvist, K., Rasmuson, T., Bergh, A., Landberg, G., & Ljungberg, B. (2004) · BJU International · doi:10.1111/j.1464-410x.2004.04605.x · Cited by 173
Yasuda, H., Yamaya, M., Nakayama, K., Sasaki, T., Ebihara, S., Kanda, A., Asada, M., Inoue, D., Suzuki, T., Okazaki, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.0436 · Cited by 170
Sensing and responding to hypoxia via HIF in model invertebrates
Gorr, T. A., Gassmann, M., & Wappner, P. (2006) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2006.01.002 · Cited by 169
Torimura, T., Sata, M., Ueno, T., Kin, M., Tsuji, R., Suzaku, K., Hashimoto, O., Sugawara, H., & Tanikawa, K. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90205-2 · Cited by 176
Negative Regulation of Hypoxic Responses via Induced Reptin Methylation
Lee, J. S., Kim, Y., Kim, I. S., Kim, B., Choi, H. J., Lee, J. M., Shin, H.-J. R., Kim, J. H., Kim, J.-Y., Seo, S.-B., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.008 · Cited by 166
Cudmore, M. J., Hewett, P. W., Ahmad, S., Wang, K.-Q., Cai, M., Al-Ani, B., Fujisawa, T., Ma, B., Sissaoui, S., Ramma, W., et al. (2012) · Nature Communications · doi:10.1038/ncomms1977 · Cited by 158
Lavie, L., Kraiczi, H., Hefetz, A., Ghandour, H., Perelman, A., Hedner, J., & Lavie, P. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.20110-040oc · Cited by 168
Apelin is a potent activator of tumour neoangiogenesis
Sorli, S. C., Le Gonidec, S., Knibiehler, B., & Audigier, Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210573 · Cited by 169
Necrosis and Glioblastoma: A Friend or a Foe? A Review and a Hypothesis
Raza, S. M., Lang, F. F., Aggarwal, B. B., Fuller, G. N., Wildrick, D. M., & Sawaya, R. (2002) · Neurosurgery · doi:10.1097/00006123-200207000-00002 · Cited by 167
Engineering vascularised tissues in vitro
Institute for BioMedical Technology, D. O. T. R., Rivron, N., Liu, J., Rouwkema, J., de Boer, J., & van Blitterswijk, C. (2008) · European Cells and Materials · doi:10.22203/ecm.v015a03 · Cited by 168
Endothelial Dysfunction and Inflammation: Immunity in Rheumatoid Arthritis
Yang, X., Chang, Y., & Wei, W. (2016) · Mediators of Inflammation · doi:10.1155/2016/6813016 · Cited by 162
Mabjeesh, N. J., Willard, M. T., Frederickson, C. E., Zhong, H., & Simons, J. W. (2003) · PubMed · Cited by 188
Lamszus, K., Lengler, U., Schmidt, N. O., Stavrou, D., Ergün, S., & Westphal, M. (2000) · Neurosurgery · doi:10.1097/00006123-200004000-00033 · Cited by 170
Maxwell, P. H. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2005.03.001 · Cited by 167
Kondo, S. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.769 · Cited by 172
Angiogenesis in epithelian ovarian cancer
Bamberger, E. S., & Perrett, C. W. (2002) · Molecular Pathology · doi:10.1136/mp.55.6.348 · Cited by 168
The multiple roles of tumour stroma
Wernert, N. (1997) · Virchows Archiv · doi:10.1007/s004280050053 · Cited by 170
Signaling angiogenesis and lymphangiogenesis
Korpelainen, E. I., & Alitalo, K. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80137-3 · Cited by 174
Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
Tanaka, T., Cao, Y., Folkman, J., & Fine, H. A. (1998) · PubMed · Cited by 180
Li, W., Kohara, H., Uchida, Y., James, J. M., Soneji, K., Cronshaw, D. G., Zou, Y.-R., Nagasawa, T., & Mukouyama, Y.-S. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.01.009 · Cited by 164
Laschke, M. W., Elitzsch, A., Vollmar, B., Vajkoczy, P., & Menger, M. D. (2006) · Human Reproduction · doi:10.1093/humrep/dei308 · Cited by 168
Targeting von Hippel-Lindau Pathway in Renal Cell Carcinoma
Patel, P. H., Chadalavada, R. S. V., Chaganti, R. S. K., & Motzer, R. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2254 · Cited by 165
Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
Cooper, B. C., Ritchie, J. M., Broghammer, C. L. W., Coffin, J. E., Sorosky, J. I., Buller, R. E., Hendrix, M. J. C., & Sood, A. K. (2002) · PubMed · Cited by 169
The Role of the Vascular Phase in Solid Tumor Growth: A Historical Review
Ribatti, D., Vacca, A., & Dammacco, F. (1999) · Neoplasia · doi:10.1038/sj.neo.7900038 · Cited by 173
Becker, C. M., Rohwer, N., Funakoshi, T., Cramer, T., Bernhardt, W., Birsner, A., Folkman, J., & D'Amato, R. J. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.061244 · Cited by 166
Dafni, H., Israely, T., Bhujwalla, Z. M., Benjamin, L. E., & Neeman, M. (2002) · PubMed · Cited by 169
Muscle Plasticity: Energy Demand and Supply Processes
Booth, F. W., & Baldwin, K. M. (1996) · Comprehensive Physiology · doi:10.1002/cphy.cp120124 · Cited by 166
Endothelial Cell HIF-1α and HIF-2α Differentially Regulate Metastatic Success
Branco-Price, C., Zhang, N., Schnelle, M., Evans, C., Katschinski, D. M., Liao, D., Ellies, L., & Johnson, R. S. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.11.017 · Cited by 168
Oliver Cassell, C. S., Stefan Hofer, O. P., Morrison, W. A., & Knight, K. R. (2002) · British Journal of Plastic Surgery · doi:10.1054/bjps.2002.3950 · Cited by 161
Onda, H., Kasuya, H., Takakura, K., Hori, T., Imaizumi, T.-A., Takeuchi, T., Inoue, I., & Takeda, J. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199911000-00013 · Cited by 165
Tissue deformation spatially modulates VEGF signaling and angiogenesis
Rivron, N. C., Vrij, E. J., Rouwkema, J., Le Gac, S., van den Berg, A., Truckenmüller, R. K., & van Blitterswijk, C. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201626109 · Cited by 165
Patterson, C., Perrella, M. A., Hsieh, C.-M., Yoshizumi, M., Lee, M.-E., & Haber, E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.23111 · Cited by 167
Fujimoto, K., Hosotani, R., Wada, M., Lee, J.-U., Koshiba, T., Miyamoto, Y., Tsuji, S., Nakajima, S., Doi, R., & Imamura, M. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00069-0 · Cited by 168
Effects of Chronic Placental Insufficiency on Brain Development in Fetal Sheep
Mallard, E. C., Rees, S., Stringer, M., Cock, M. L., & Harding, R. (1998) · Pediatric Research · doi:10.1203/00006450-199802000-00018 · Cited by 167
Patterson, C., Perrella, M. A., Endege, W. O., Yoshizumi, M., Lee, M. E., & Haber, E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118816 · Cited by 169
May, D., Itin, A., Gal, O., Kalinski, H., Feinstein, E., & Keshet, E. (2005) · Oncogene · doi:10.1038/sj.onc.1208325 · Cited by 167
Self-citationNitric Oxide-Mediated Regulation of Chemosensitivity in Cancer Cells
Matthews, N. E., Adams, M. A., Maxwell, L. R., Gofton, T. E., & Graham, C. H. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.24.1879 · Cited by 168
Kallistatin is a new inhibitor of angiogenesis and tumor growth
Miao, R. Q., Agata, J., Chao, L., & Chao, J. (2002) · Blood · doi:10.1182/blood-2002-01-0185 · Cited by 166
STEWART, R. J., PANIGRAHY, D., FLYNN, E., & FOLKMAN, J. (2001) · Journal of Urology · doi:10.1097/00005392-200102000-00095 · Cited by 164
Constitutive and inducible expression and regulation of vascular endothelial growth factor
Xie, K., Wei, D., Shi, Q., & Huang, S. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.04.003 · Cited by 163
Funatsu, H., Yamashita, H., Ikeda, T., Nakanishi, Y., Kitano, S., & Hori, S. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01323-5 · Cited by 169
Saadeh, P. B., Mehrara, B. J., Steinbrech, D. S., Dudziak, M. E., Greenwald, J. A., Luchs, J. S., Spector, J. A., Ueno, H., Gittes, G. K., & Longaker, M. T. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.4.c628 · Cited by 164
Spectrum of Activity and Mechanism of Action of VEGF/PDGF Inhibitors
Homsi, J., & Daud, A. I. (2007) · Cancer Control · doi:10.1177/107327480701400312 · Cited by 160
Oh, H., Takagi, H., Otani, A., Koyama, S., Kemmochi, S., Uemura, A., & Honda, Y. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012074399 · Cited by 161
pH sensing at the intersection of tissue homeostasis and inflammation
Hajjar, S., & Zhou, X. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.08.008 · Cited by 176
Metadata
- Authors
- Shweiki, D., Itin, A., Soffer, D., & Keshet, E.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Venue
- Nature
- Published
- 1992-10
- Volume
- 359
- Issue
- 6398
- Pages
- 843-845
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2015344488
- Cited by
- 4,617
- References
- 28
- Citations by year
- 2026: 37 · 2025: 40 · 2024: 70 · 2023: 70 · 2022: 89 · 2021: 90 · 2020: 94 · 2019: 98 · 2018: 81 · 2017: 83 · 2016: 114 · 2015: 104 · 2014: 128 · 2013: 137 · 2012: 141
- FWCI
- 29.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- vascular endothelial growth factor, hypoxia, angiogenesis, neovascularization, glioblastoma, tumor necrosis, tumor hypoxia, tumor vasculature
- MeSH terms
- Animals, Brain Neoplasms, Cell Division, Endothelium, Vascular, Glioblastoma, Humans, Lymphokines, Necrosis, Neovascularization, Pathologic, RNA, Messenger, RNA, Neoplasm, Tumor Cells, Cultured, Cell Hypoxia, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.